{"paper_id":"b28a22b0-14ce-4d91-91f9-59c02862cf31","body_text":"Female infertility places a substantial psychological, social, medical and economic burden on the couple and community. Over 70% of female infertility cases results from low ovarian reserve or dysfunction, issues with the uterus and cervix, tubal issues, and endometriosis and pelvic adhesions. However, 30% of cases are of unknown etiology  1 , 2 . Vitamin D deficiency is prevalent in reproductive age women, and seasonal reproductive capacity may be in part a consequence of variations in Vit D levels. However, the literature to date is inconclusive and does not confirm a role for Vit D in female infertility  3 - 6 . The total fertility rate in Saudi Arabia has dropped from 7.175 in 1950 to 2.148 in 2023; with a steady decline starting from 1980 ( https://www.macrotrends.net/countries/SAU/saudi-arabia/fertility-rate , accessed May 20, 2023). To the Saudi ministry of health, causes of women infertility include ovulation disorders, polycystic ovary syndrome (PCOS), amenorrhea, pituitary dysfunction, endometriosis, fallopian tube blockage due to salpingitis as in pelvic inflammatory disease, previous infection with gonorrhea and chlamydia, or any abdominal surgery, and uterine abnormalities such as uterine fibroids ( https://www.moh.gov.sa/en/HealthAwareness/Educational-Content/wh/Pages/036.aspx , accessed May 20, 2023). In a Saudi nation-wide representative sample of 15810 general population women aged 18-44 years, rate of involuntary infertility ranged from 25 to 50% within one year 7 , 8 . In Arar, Saudi Arabia, the prevalence of infertility among followed up women was 65.3%; 19.8% of them were primary and 80.2% were secondary infertility; ovulation defect constituted 24.6%, followed by the polycystic ovary (21.8%), tubal adhesions or obstruction (6.7%), endometriosis (3.2%), and uterine fibroid (3.0%)  9 . In Najran, Saudi Arabia, 65% of followed up women infertility was primary and 35% was secondary infertility, with PCO disease as the most common (56%), followed by fibroids (22%), endometrial polyps (9%), adenomyosis (5%), hydrosalpinx (4%), congenital abnormality (2%), and other causes (1%)  10 . Among Saudi women followed up in Riyadh city, 67.0% had secondary infertility, while 33.0% had primary infertility. Defective ovulation constituted 28.9%, tubal adhesion or obstruction was 7.4%, and male factors was 12.6%  11 . To Khadawardi prevalence of infertility was 23.3% among followed up Saudi women, with endometriosis constituting 10.7%  12 .\nVit D is a steroidal preprohormone with extensive immunomodulatory, anti-inflammatory, and metabolic functionality, including cell cycle control, insulin secretion, and anti-autoimmunity. The subsequent hydroxylation of Vit D to its prohormone 25-hydoxy-form (calcidiol) occurs in the liver and other tissues, and then further to the hormone form 1,25-dihydroxy-chole/ergo-calciferol form (calcitriol) in the kidney and other tissues (including epithelial and immune cells) is controlled by its own level and by various hormones, sterols and growth factors  4 , 5 , 13 . Among 1000 genes controlled by Vit D receptor-mediated transcription and membrane-receptor signaling, those implicated in women infertility include insulin secretion and action, and expression of Homeobox 10, miR222, antimüllerian hormone, immunomodulatory and anti-inflammatory cytokines/chemokines, steroidogenesis, angiogenesis and antioxidant defense  14 - 20 . Deficiency of Vit D, an essential micronutrient, is a global epidemic, as a consequence of low levels obtained by consumption of unfortified foods and insufficient production via conditional synthesis from 7-dehydocholesterol upon exposure of epidermal keratinocytes to UVB rays. Blood levels vary depending on a number of individual factors, including genetic polymorphisms, skin color and ethnicity, body mass index (BMI), and supplement use, as well as by environmental, life-style, food fortification policies, drug and pollutant exposure, and seasonal variations. Conditions that affect absorption, digestion and transport of the vitamin also lead to variations in blood levels. In the circulation, calcitriol is approximately 1000 times lower than calcidiol  4 , 5 , 13 , 21 - 23 . Discrepancy among published literature considering Vit D role in female infertility may also originate from variance in the pre- and analytical factors.\nThe putative role for Vit D in female reproduction is indicated by uterine hypoplasia and anovulation in Vit D receptor (VDR) and 1α-hydroxylase knockout mice, (reviewed by Lerchbaum and Obermayer-Pietsch) 24 . Expression of HOXA10, required for multiple aspects of fertility - including the maintenance of a healthy pregnancy, is upregulated by Vit D. The VDR and metabolizing enzymes are expressed in female reproductive and endocrine tissues. Vit D deficiency is shown in the clinic and lab to result in poorer fertility and impaired functionality of the reproductive system, PCOS, endometriosis and pre-term birth, along with many systemic conditions that include increased insulin resistance 4 , 5 , 25 - 27 . Vit D controls the expression of aromatase and estrogen production, and increase sensitivity to FSH and human chorionic gonadotropin secretion, and estrogen and progesterone synthesis in human placenta  28 . Vit D supplementation resulted in significant reductions in total testosterone, free androgen index, hirsutism, and C-reactive protein (CRP) levels, as well as a significant increase in sex hormone binding globulin and total antioxidant capacity  29 , 30 . Serum calcidiol concentration significantly correlated with female infertility with insignificant difference in its level between primary and secondary causes  6 . Low Vit D is correlated with poorer in vitro fertilization (IVF) outcomes, folliculogenesis and reduced ovarian reserves  5 , 27 , 31 , 32 . In IVF, women with normal serum Vit D levels (comparable with follicular levels) have a significantly higher chance of euploid blastocyst production than deficient patients 33 . In healthy reproductive-aged Caucasian women, Vit D levels are significantly negatively correlated with multiple sex hormones  34 . Polymorphisms in the Vit D binding protein (VDBP) that reduce its expression are associated with metabolic syndrome and low Vit D in patients and controls; however, this is not directly correlated with PCOS  35 . In Pakistani women, one VDBP polymorphism, which activates 1a-hydroxylase, and inactivates 24-hydroxylase, exhibits an inverse correlation between Vit D levels and PCOS  36 . Consequently, many fertility clinics advise screening for (generally as calcidiol levels) and supplementation of Vit D, most critical for women who are not at risk of ovarian hyper-stimulation but suffer from PCOS or similar. Supplementation of Vit D led to higher rates of positive pregnancy tests than in unsupplemented cases  4 , 5 , 25 , 27 , 37 . Almost 96% of women in IVF treatment were Vit D deficient/insufficient, and this negatively correlates with duration of infertility and BMI  38 .\nProposing an inverse relationship, herein we determine the correlation between Vit D biomarkers, calcidiol, calcitriol and their direct ratio, with multiple causes of infertility in a local population of healthy and infertile Saudi women.\n\nThis case-controlled study was conducted between September 12, 2018 and September 30, 2019 at Aljouf Maternity and Children's Hospital and College of Medicine, Jouf University, Sakaka, Saudi Arabia. The bioethical protocols (#6-16-4/40) were approved by committees at the university and Ministry of Health, and informed consent was provided by all participants included - in adherence to the provisions of the Declaration of Helsinki. Participants were excluded if they demonstrated unwillingness, have previous pelvic surgery, male factor infertility, or other co-morbidities include thyroid disorders and chronic conditions (i.e., liver, kidney, autoimmune diseases and diabetes). Patients prescribed glucocorticoids, antifungal, antiepileptic and antiretroviral drugs were also excluded, due to effects of these drugs for Vit D metabolism. Infertility (post-male factor exclusion) results in no conception after one year of unprotected intercourse  1 . No prior pregnancy is termed primary infertility.\n105 participants were included in the study, of which 25 were healthy (previously pregnant; aged 27.6 ± 5.3 years) controls and 80 were infertile (aged 27.76 ± 5.052 years with a duration of 3.538 ± 1.807 years). Of the infertile women, there were three groups based on etiology: 30 with PCOS, 27 with other etiologies (incorporating tubal n = 6, tubo-peritoneal n = 5, cervical n = 6 and uterine n = 5 issues and anovulation n = 5), and 23 of unexplained etiology. Unexplained classification only occurred after full investigations, including laparoscopy. These groupings were further defined by primary (n = 35)/secondary (n = 45) infertility status. A complete medical history was taken for all patients, and weight, height and vital signs were recorded and a complete examination was conducted systematically. Following laboratory and infertility investigations, individuals with abnormal findings were excluded from the study.\nSerum was recovered from 5 mL peripheral blood samples via clotting and centrifugation. Aliquots were stored at -80°C. Calcidiol (ng/mL; cat# SL2762Hu) and calcitriol (pg/mL; cat# SL2845Hu) were measured using ELISA kits in accordance with instructions (Sunlong Biotech Co. Ltd., Zhejiang, China). Participants were grouped according to clinically designated levels, from severely deficient < 10 ng/mL to high/toxic at 50/> 80 ng/mL  39 - 42 . However, the clinical cutoff levels do not pertain to female infertility. We also determined the direct calcitriol/calcidiol ratio for all participants.\nData analysis used SPSS (Statistics package for social sciences, Version 23.0, IBM Corp, Armonk, NY) and Prism-7.0 Package (GraphPad Software, San Diego, CA). Qualitative statistics were described as frequencies/percentages, while quantitative as mean ± standard deviation (SD)/median ± interquartile range (IQR). Variable distribution was determined by the Kolmogorov-Sminov test, non-normal variable distribution was identified by a significant p-value. Kruskal-Wallis test was used followed by Mann-Whitney test for multiple comparisons of Vit D levels in the groups. The area under the curve (AUC) was determined by ROC for both biomarkers and their ratio to discriminate the cases and controls, where higher AUC represent greater sensitivity and specificity for the biomarker. A p-value of ≤0.05 at a confidence level of 95% was considered significant.\n\nComparisons of the characteristics and investigations among participants ( Table 1 )\nVariations in serum calcidiol, calcitriol and their ratio as biomarkers for vitamin D status when investigating infertile (n = 80) and fertile (n = 25) women, described as range, mean ± SDM and number\nParticipant age was not a significant factor between controls and infertile group/subgroups, with the exception of secondary unexplained infertility vs. PCOS (P < 0.01) and primary PCOS patients (P < 0.01).\nPCOS individuals exhibited highest BMIs, while unexplained infertility group were the lowest, specifically primary conditions. Controls vs. infertility group and subgroups were significantly different P < 0.01 and P < 0.001, respectively, as were the infertile group vs. PCOS (P < 0.001), primary PCOS (P < 0.001), unexplained (P < 0.01) and primary unexplained cases (P < 0.01). Further, PCOS group and sub-groups were significantly different from unexplained and subgroups, and other and secondary other etiologies (P < 0.001).\nNaturally, healthy control showed significantly higher gravidity than the infertile group and subgroups (P < 0.001), while primary infertility had zero gravidity, and within the infertile group, subgroups PCOS and its groups had the lowest gravidity (P < 0.001).\nHealthy participants had significantly higher parity than the infertile group and subgroups (P < 0.001), primary infertile group had zero parity, while in the infertile cohort PCOS and subgroups exhibited the lowest parity (P < 0.001). Primary vs. secondary groups were also significantly different (P < 0.05).\nPatients with unexplained infertility had the longest duration (P < 0.05), with other etiologies next, and PCOS individuals the shortest.\nWith the exception of primary other etiology cases, healthy controls exhibited significantly higher levels of calcidiol than all infertile groups (P < 0.001). However, the difference for other and secondary etiologies were less, with P< 0.01 and P< 0.05, respectively. Within the infertility subgroups only other and secondary etiologies vs. PCOS and primary PCOS were significantly different (P < 0.05). For all healthy and infertile groups the levels of calcidiol was not clinically severely deficient. For the controls, 16 (64%) were insufficient, 4 (16%) were normal, 2 (8%) deficient, and 3 (12%) had toxic levels (> 80 ng/mL). For the patients, over a half (44, 55%) were deficient, 30 (37.5%) insufficient, and 6 (7.5%) had normal levels. Over 92% of patients and 72% of controls exhibited insufficient/deficient levels.\nWith the exception of infertile primary other etiology cases, healthy controls exhibited higher levels of calcitriol than all other infertile groups (P < 0.001). Within the infertile subgroups, only other- and secondary other etiologies vs. PCOS and primary PCOS exhibited a significant difference (P < 0.05). At a cutoff of 100 pg/mL, 17 control (68%) but only 4 (5%) infertile women (specifically other etiologies) had normal levels.\nControls showed a higher ratio than all infertile subgroups (P < 0.001 overall, P < 0.05 vs secondary PCOS and primary unexplained, P < 0.01 vs. secondary unexplained, and no significant difference vs. primary other etiologies). Among infertile subgroups there were no significant differences. At a cutoff of 3.333 (100 pg/mL calcitriol vs. 30 ng/mL calcidiol), 64% ( 16 ) controls and 16.25% ( 13 ) infertile patients had normal ratios. Of the infertile cases, five were PCOS (3 primary, 2 secondary), five other etiologies (3 primary, 2 secondary), and four unexplained (all secondary).\nGiven that BMI is higher for the infertile patients than the controls, normalization of the levels of biomarkers for BMI (ng/mL / kg/m 2 ) demonstrated greater levels of deficiency in the infertile group and subgroups for all markers.\nComparing the patients with primary vs. secondary causes showed nonsignificant difference due to the big differences among primary subgroups, and among secondary subgroups, for the three biomarkers.\nBMI was the only normally distributed independent variable (P < 0.001). Using the Mann Whitney U test, data for calcidiol, calcitriol and their ratios were cross tabulated and identified a significant difference between cases and controls (2-sided Test asymptotic significance = 0.000;  Figure 1 ). For categorical data, we used the Kruskal-Wallis test to cross-tabulate calcidiol, calcitriol and their ratio and found significant differences across the categories of P < 0.0001, <0.001, and < 0.040, respectively ( Table 2 ). From ROC curve analysis, calcitriol was the best indicator of fertility AUC = 0.909 ± 0.031 (0.714-0.9.3), using the nonparametric approach, at asymptotic 95% CI (P < 0.001), followed by calcidiol AUC = 0.808 ± 0.048 (0.714-0.903); P < 0.001, and the ratio AUC = 0.740 ± 0.065 (0.612-0.869); P < 0.001 ( Figure 2 ).\nMann-Whitney U test for cross tabulation of calcitriol, calcidiol and their ratio for infertile (n = 80) and fertile (n = 25) women. Significant differences noted across cases and controls for all biomarkers\nKruskal Wallis Test for cross tabulation of calcitriol, calcidiol and their ratio for infertile (n = 80) and fertile (n = 25) women, stratified for infertility. Data presented as mean ± standard deviation from the mean (SDM), median ± interquartile range (IQR), and P values\nROC curve analysis of AUC to determine ability of calcitriol, calcidiol, and their ratio to distinguish fertile (n = 25) from infertile (n = 80) women. Calcitriol exhibited the highest sensitivity and specificity; however calcidiol and the ratio were also predictive\n\nIn healthy controls, the selected test characteristics were significantly positively correlated with each other. Vit D biomarkers exhibited a negative correlation with these characteristics, although was only significant for BMI vs. ratio. The ratio correlated negatively with calcidiol and positively with calcitriol ( Table 3 ).\nCorrelation of test characteristics in fertile women (n=25). Presented data are r/P values of non-parametric spearman correction analysis\nInfertile patient characteristics were significantly positively correlated with each other, with BMI significantly correlated with all characteristics. Calcidiol showed only significant positive correlation with gravidity, while BMI was nonsignificantly negatively correlated. Conversely, calcitriol was negatively associated with the characteristics, achieving significance vs. age and duration. The ratio exhibited a positive (nonsignificant) correlation with BMI, and negative association with the other characteristics. The ratio was positively correlated with calcidiol and calcitriol, with vs. calcitriol being significant ( Table 4 ).\nCorrelation between characteristics and Vit D biomarkers in infertile cases (n = 80). Data shown are r/P values of non-parametric Spearman correction analysis\nOverall, fewer significant correlations were identified. Significant positively correlated data included, duration vs. age, parity and BMI; BMI vs. age; parity vs. age and gravidity. For biomarkers, calcitriol was significantly positively associated with only calcidiol and the ratio. ( Table 5 ).\nPCOS-associated infertility patients (n = 30) and vitamin D biomarkers. Correlations are shown as r/P values of non-parametric Spearman correction analysis\nSignificant positive correlations were observed for duration vs. age (r = 0.850; P < 0.0001), and vs. BMI (r = 0.443; P = 0.022); BMI vs. age (r = 0.593; P = 0.0023). For biomarkers, calcitriol was significantly positively associated with only calcidiol and the ratio (r = 0.518; P = 0.008, and r = 0.638; P = 0.009, respectively).\nSignificant positive correlations were observed for duration vs. age (r = 0.836; P = 0.004), parity (r = 0.844; P = 0.016), and BMI (r = 0.647; P = 0.033). For biomarkers only calcitriol was significantly correlated with calcidiol (r = 0.820; P = 0.005).\nCalcitriol\n0.615/0.0002\nSignificant positive correlations were observed for age vs. gravidity, parity, and duration; gravidity vs. parity, and BMI; and parity vs. BMI. For biomarkers, calcidiol was significantly positive vs. calcitriol and BMI. Calcitriol significantly correlated negatively vs. age and duration, and positively vs. ratio. Ratio showed similar correlations vs. age and duration ( Table 6 ).\nInfertility of unexplained etiology (n = 23) and vitamin D biomarkers. Correlations are shown as r/P values of non-parametric Spearman correction analysis\nSignificant positive correlation was observed only for duration vs. age (r = 0.873; P < 0.010), and calcidiol vs. BMI (r = 0.883; P = 0.008).\nSignificant positive correlations were observed for age vs. duration (r = 0.801; P = 0.0002), gravidity vs. parity (r = 0.735; P = 0.0008). For biomarkers, significant negative correlations were noted for calcitriol and the ratio vs. age (r = -0.640; P = 0.0045; r = -0.771; P = 0.0004) and duration (r = -0.638; P = 0.0046; r = -0.683; P = 0.0023). While calcitriol correlated positively with the ratio (r = 0.849; P < 0.0001).\nSignificant positive correlations were noted for age vs. gravidity, parity and duration; gravidity vs. parity, and BMI; and parity vs. BMI. For biomarkers, significant negative correlations were noted for calcidiol vs. duration; calcitriol vs. all characteristic, except with BMI which was positive. Inter-biomarker relationships showed positive correlation for calcidiol vs. calcitriol, and calcitriol vs. ratio. The ratio showed negative correlation with age, gravidity and parity, but positive vs. BMI ( Table 7 ).\nOther etiology infertility cases (n = 27) correlation with vitamin D biomarkers, described as r/P values of non-parametric Spearman correction analysis\nSignificant positive correlations were observed only for BMI vs. calcitriol and vs. ratio (r = 0.786; P = 0.024 for both), and calcitriol and ratio (r = 0.893; P = 0.006).\nSignificant positive correlations were observed for age vs. gravidity and BMI (r = 0.845; P < 0.0001; r = 0.731; P = 0.030, respectively); gravidity vs. parity and duration (r = 0.719; P = 0.0002; r = 0.476; P = 0.017, respectively); parity vs. duration (r = 0.627; P < 0.002). Negative correlations were noted for age vs. parity and duration (r = -0.426; P < 0.0001; r = -0.382; P = 0.0001, respectively); gravidity vs. BMI (r = -0.407; P = 0.037); and parity vs. BMI (r = -0.603; P < 0.003). For biomarkers and characteristics, significant negative correlations were noted for calcidiol vs. duration (r = -0.462; P = 0.020); calcitriol vs. all (except BMI) (r = -0.598; P = 0.0006 with age, r = -0.560; P = 0.005 with gravidity, r = -0.693; P = 0.0004 with parity, and r = -0.588; P = 0.003 with duration); ratio vs. gravidity (r = -0.616; P < 0.002), parity (r = -0.740; P < 0.0001), and duration (r = -0.434; P = 0.028). Positive correlations were observed for calcitriol vs. BMI (r = 0.529; P = 0.008); ratio vs. age (r = 0.845; P < 0.003) and BMI (r = 0.617; P < 0.002). Inter-biomarker analysis revealed positive associations for calcidiol vs. calcitriol (r = 0.599; P = 0.0005); calcitriol vs. ratio (r = 0.871; P < 0.0001).\n\nWhile our study is not unique, it offers new insight into infertility and association with vitamin D in our area, as Vit D levels in reproductive-aged Aljouf Saudi women have not been published. It also shows the applicability of the biomarkers. We show that Vit D is insufficient/deficient in 82% of healthy participants, while cases expressed a rate of 90 – 100%. We found that calcitriol was most sensitive in differentiating between these groups.\nWe describe the situation where calcidiol is the prohormone and calcitriol the active form, in which calcitriol is the more precise discriminant factor  26 . Similar to the current literature, including meta-analyses  6 , 25 , 26 , 43 - 47 , we found wide-spread Vit D deficiency/insufficiency among healthy controls, and significantly worse scenarios in infertile women. While the three biomarkers exhibited significant difference between controls and cases, we found calcitriol > ratio > calcidiol for discrimination. For individual disease categories, we found biomarker performance was worse for PCOS, then unexplained- and other etiologies. On the whole, a positive correlation was observed for healthy control characteristics, while only the ratio was negatively correlated with BMI. Similarly for infertile patients, positive correlations were observed for all with the exception of BMI which was negatively correlated with the three biomarkers and calcidiol vs gravidity which was positively correlated.\nAll of the other etiology infertility patients (cervical, uterine, tubal or peritoneal origin or anovulation) exhibited low Vit D levels. Low Vit D is significantly correlated with endometriosis risk and severity, as well as a number of other gynecological conditions including leiomyoma, uterine myoma, and dysmenorrhea  30 , 34 , 48 - 54 . For severe cases of endometriosis, calcidiol levels were half of those in healthy controls or in women with less severe endometriosis. Contrary to our findings, calcidiol was positively associated with gravidity and parity  55 , while we noted negative associations between both of calcitriol and ratio vs. gravidity and parity. Some in vitro research noted an effect of calcitriol on reduction of inflammatory markers and factors associated with endometrial stroma cells  49 , others purported that the data is insufficient to definitively indicate a Vit D-endometriosis relationship  31 , 56 , 57 . However, we do know that estradiol and progesterone are inversely correlated with calcidiol levels  58 . Endometriosis patients showed significantly higher calcidiol levels but calcitriol was nonsignificantly different from healthy controls  49 , 59 . Calcidiol exhibits significant seasonal variation while calcitriol does not  60 - 62 .\nThe pathogenesis of endometriosis may be associated with high levels of Vit D resulting in impaired elimination of endometrial cells in the peritoneal cavity  63 . Our findings were contrary to these, we noted low calcidiol and consistent and lower levels of calcitriol in the other etiology patients, and calcidiol correlated negatively with only the duration, while calcitriol and the ratio were negatively correlated with all characteristics except BMI. This may be related to a “change point issue”, wherein serum and follicular fluid levels of AMH are negatively correlated with Vit D to ~30 ng/mL and thereafter show a positive insignificant relationship with tubal factor infertility patients. Further, significant negative seasonal variations were noted for both  61 , which may be indicative of the critical nature of lower rather than higher Vit D levels. The impact of Vit D in IVF and associated parameters including resulting pregnancy is controversial  28 . However, investigating IVF outcomes in an egg-donor model, which separates the effect of Vit D on eggs and endometrium, data indicates that Vit D effect may occur via the endometrium. Deficiency and insufficiency levels of Vit D exhibited similar negative consequences  64 .\nA study of Iranian women reported similar data to our PCOS cases, whereby the lowest Vit D levels were noted but did not exhibit any correlation with patient characteristics (or between the biomarkers). Vit D levels in serum and follicular fluid were lower in PCOS patients compared to controls and correlated negatively with BMI. Vit D controls insulin expression and sensitivity, and in turn α1-hydoxylase expression and calcitriol level  65 . Low levels of Vit D were linked to both PCOS and associated risk factors such as obesity and insulin resistance  31 , 37 , 45 , 66 . In the Iranian study, lower Vit D was noted among PCOS-infertile women, specifically those who were obese, than controls  67 . Ovulation is significantly improved in PCOS cases where low Vit D is treated  68 , 69 , and cases with higher serum and follicular levels had significantly increased IVF pregnancy rate than others  70 . Later in the reproductive period, Vit D and ovarian reserve are significantly positively correlated  71 . Ovarian stimulation outcome in PCOS is significantly associated with Vit D deficiency  72 . PCOS patients show a negative correlation with Vit D vs testosterone, SHBG, free androgen index, DHEAS levels, and LH/FSH ratio, which is worse in obese patients 73 , 74 .\nHowever, pregnancy outcome was not significantly associated with Vit D levels  75 . Post-confounder normalization, PCOS patients showed association with higher Vit D levels; however, this did not lead to improved metabolic function  62 . Serum Vit D was not associated with PCOS or AMH  76 , and there was no significant correlation between conceiving or miscarriage risk with pre-pregnancy Vit D levels  3 . These studies may be confounded by the fact that both patients and controls exhibit insufficient/deficient levels of Vit D 62 , or that a low cutoff level (20 ng/mL) is used  6 , 76 - 78 . This is a critical point as the recommended reproductive thresholds for serum calcidiol is higher (≥ 45 ng/mL) than for the non-pregnant population  64 , 79 .\nOur study found a significant reduction in Vit D in unexplained/known etiology cases, with positive correlation noted between calcidiol vs. BMI, and negative between calcitriol/ratio vs. duration and age. Contrary to this, there was no noted association between Vit D deficiency and ovarian stimulation outcome  72 . However, in one African study, incorporating all etiologies, with a major unexplained, infertile patients did not exhibit lower Vit D than the controls  80 . Nor was correlation observed with Vit D and follicular count/AMH 77 , 78 . While follicular and serum Vit D levels are putative markers of egg and embryo quality, and higher levels result in higher pregnancy chance, a positive association has only been observed and no significant correlations reported  81 , 82 .\nGiven the seasonal variation in calcidiol, we assessed the efficacy of calcidiol, calcitriol and their ratio as predictive markers for infertility vs. healthy controls. Calcidiol was inferior to calcitriol in predicting infertility and negatively correlated with the clinical characteristics of all studies etiologies. This study provides insight into the variation of these three makers as they relate to infertility. In summary, the lowest rate of Vit D deficiency was in PCOS cases and is similar to unexplained cases, while other etiology preformed marginally better. Calcidiol showed negative correlation with BMI in patients, while calcitriol and ratio exhibited a positive correlation with BMI of healthy controls. All biomarkers were negatively correlated with disease duration in all patients. Consequently, it is reasonable to predict an association for Vit D deficiency and unexplained factor infertility. The notion of nonsignificant differences for the three biomarkers comparing the primary vs. the secondary causes of infertility in this study, due to the big difference among subgroups of each, was previously reported  6 .\nThe study was limited by the small case numbers, especially in the subgroups, a year round sample collection period could have allowed seasonal variation, and, since we did not estimate reproductive hormones levels, we did not analyze their correlations with Vit D biomarkers.\n\nOver 90% of the infertile women in the study exhibited Vit D deficit as determined by the three biomarkers. Lowest levels were reported for PCOS and unexplained reasons, and then other etiologies. Calcitriol was the optimal predictor of infertility, and the ratio was discriminatory for healthy vs. infertile participants. Given the seasonal nature of calcidiol, we recommend the use of calcitriol and their ratio as the more precise markers. It is vital that standardized no-skeletal Vit D levels are fully characterized in the female reproductive-aged populations. Our data corroborate a role for Vit D in unexplained infertility, and indicate a therapeutic role for Vit D supplementation.","source_license":"CC-BY-4.0","license_restricted":false}